These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

554 related articles for article (PubMed ID: 14680965)

  • 1. High-level expression and one-step purification of recombinant dengue virus type 2 envelope domain III protein in Escherichia coli.
    Jaiswal S; Khanna N; Swaminathan S
    Protein Expr Purif; 2004 Jan; 33(1):80-91. PubMed ID: 14680965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacterially expressed and refolded envelope protein (domain III) of dengue virus type-4 binds heparan sulfate.
    Pattnaik P; Babu JP; Verma SK; Tak V; Rao PV
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 846(1-2):184-94. PubMed ID: 17011249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-level expression of recombinant dengue virus type 2 envelope domain III protein and induction of neutralizing antibodies in BALB/C mice.
    Zhang ZS; Yan YS; Weng YW; Huang HL; Li SQ; He S; Zhang JM
    J Virol Methods; 2007 Aug; 143(2):125-31. PubMed ID: 17532481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recombinant envelope glycoprotein domain III of dengue virus inhibit virus infection].
    Lu P; Wei Y; Cao SC; Li JD; Liu QZ; Zhang QF; Li C; Miao F; Zhang S; Hang XT; Liang MF; Li DX
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Jun; 22(3):177-9. PubMed ID: 19031695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production and characterization of recombinant dengue virus type 4 envelope domain III protein.
    Tripathi NK; Babu JP; Shrivastva A; Parida M; Jana AM; Rao PV
    J Biotechnol; 2008 Apr; 134(3-4):278-86. PubMed ID: 18342971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid purification of recombinant dengue and West Nile virus envelope Domain III proteins by metal affinity membrane chromatography.
    Tan LC; Chua AJ; Goh LS; Pua SM; Cheong YK; Ng ML
    Protein Expr Purif; 2010 Nov; 74(1):129-37. PubMed ID: 20600950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a simple fed-batch process for the high-yield production of recombinant Japanese encephalitis virus protein.
    Tripathi NK; Shukla J; Biswal KC; Lakshmana Rao PV
    Appl Microbiol Biotechnol; 2010 May; 86(6):1795-803. PubMed ID: 20177885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant dengue virus type 3 envelope domain III protein from Escherichia coli.
    Tripathi NK; Shrivastava A; Biswal KC; Rao PV
    Biotechnol J; 2011 May; 6(5):604-8. PubMed ID: 21538895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of recombinant soluble dengue virus 2 envelope domain III protein production in Escherichia coli trxB and gor double mutant.
    Saejung W; Puttikhunt C; Prommool T; Sojikul P; Tanaka R; Fujiyama K; Malasit P; Seki T
    J Biosci Bioeng; 2006 Oct; 102(4):333-9. PubMed ID: 17116581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of neutralizing antibodies and T cell responses by dengue virus type 2 envelope domain III encoded by plasmid and adenoviral vectors.
    Khanam S; Khanna N; Swaminathan S
    Vaccine; 2006 Oct; 24(42-43):6513-25. PubMed ID: 16860446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression, purification and characterization of in vivo biotinylated dengue virus envelope domain III based tetravalent antigen.
    Batra G; Talha SM; Nemani SK; Dhar N; Swaminathan S; Khanna N
    Protein Expr Purif; 2010 Nov; 74(1):99-105. PubMed ID: 20435144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of neutralizing antibodies specific to dengue virus serotypes 2 and 4 by a bivalent antigen composed of linked envelope domains III of these two serotypes.
    Khanam S; Etemad B; Khanna N; Swaminathan S
    Am J Trop Med Hyg; 2006 Feb; 74(2):266-77. PubMed ID: 16474083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression, purification and evaluation of diagnostic potential and immunogenicity of dengue virus type 3 domain III protein.
    Reddy PB; Pattnaik P; Tripathi NK; Srivastava A; Rao PV
    Protein Pept Lett; 2012 May; 19(5):509-19. PubMed ID: 22486646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dengue-1 envelope protein domain III produced in Pichia pastoris: potential use for serological diagnosis.
    Cardoso SA; Paixão VF; Oliveira MD; Honda ER; Oliveira LL; da Silva CC; De Paula SO
    Protein Expr Purif; 2013 Nov; 92(1):9-13. PubMed ID: 23993978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A custom-designed recombinant multiepitope protein as a dengue diagnostic reagent.
    AnandaRao R; Swaminathan S; Fernando S; Jana AM; Khanna N
    Protein Expr Purif; 2005 May; 41(1):136-47. PubMed ID: 15802231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the interaction of domain III of the envelope protein of dengue virus with putative receptors from CHO cells.
    Huerta V; Chinea G; Fleitas N; Sarría M; Sánchez J; Toledo P; Padrón G
    Virus Res; 2008 Nov; 137(2):225-34. PubMed ID: 18723056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An envelope domain III-based chimeric antigen produced in Pichia pastoris elicits neutralizing antibodies against all four dengue virus serotypes.
    Etemad B; Batra G; Raut R; Dahiya S; Khanam S; Swaminathan S; Khanna N
    Am J Trop Med Hyg; 2008 Sep; 79(3):353-63. PubMed ID: 18784226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Refolding and purification of recombinant human PDE7A expressed in Escherichia coli as inclusion bodies.
    Richter W; Hermsdorf T; Kronbach T; Dettmer D
    Protein Expr Purif; 2002 Jun; 25(1):138-48. PubMed ID: 12071709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production, purification and characterization of recombinant dengue multiepitope protein.
    Tripathi NK; Shrivastva A; Pattnaik P; Parida M; Dash PK; Jana AM; Rao PV
    Biotechnol Appl Biochem; 2007 Feb; 46(Pt 2):105-13. PubMed ID: 16999685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression and function analysis of dengue virus type 1 to 4 envelope domain III recombinant fusion protein].
    Niu GY; Lu P; Zhang S; Zhang QF; Li C; Liang MF; Xu F; Li DX
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Jun; 24(3):161-4. PubMed ID: 21186514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.